GALE

Galena Biopharma Reports Third Quarter 2012 Financial Results

[at noodls] – LAKE OSWEGO, Ore., Nov. 13, 2012 (GLOBE NEWSWIRE) — Galena Biopharma, Inc. (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet … moreView todays social media effects on GALEView the latest stocks trending across Twitter. Click to view dashboard […]

PropThink: Galena: One of Biotech’s Most Vulnerable Names

[ACN Newswire] – On the surface, Galena Biopharma (NASDAQ:GALE) appears a late-stage oncology company focused on developing a promising breast cancer therapy. Beneath this mask, however, is a business rife with problems. … moreView todays social media effects on GALEView the latest stocks trending across Twitter. Click to view dashboard […]

Galena Biopharma to Present at the Lazard Capital Markets 9th Annual Healthcare Conference

[at noodls] – LAKE OSWEGO, Oregon, Nov. 8, 2012 (GLOBE NEWSWIRE) — Galena Biopharma, Inc. (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments that address major unmet … moreView todays social media effects on GALEView the latest stocks trending across Twitter. Click to view dashboard […]